Genomic Testing Cooperative, LCA
Lake Forest, CA
- UEI
- NMAYSL9NW6M9
- CAGE
- 87PF1
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 25371 Commercentre Dr, Lake Forest, CA 92630, USA
- Website
- genomictestingcooperative.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $288,000 |
| FY2025 | $205,500 |
| FY2024 | $174,000 |
| FY2023 | $108,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $288,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Infinity Biologix LLC D.b.a. Sampled | Piscataway, NJ | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Mission Bio, Inc. | South San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Baylor Miraca Genetics Laboratories LLC | Houston, TX | 621511 Medical Laboratories |
| Self Research Institute | Greenwood, SC | 621511 Medical Laboratories |
| Seqmatic, LLC | Fremont, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Genomic Testing Cooperative, LCA Genomic Testing Cooperative Division is a self-certified small disadvantaged business based in Lake Forest, California that provides next-generation sequencing (NGS) and hematology panel testing services exclusively to the National Heart, Lung and Blood Institute (NHLBI) as a prime contractor on firm fixed-price purchase orders. The firm operates entirely in the unset-aside commercial market, competing on capability and pricing rather than set-aside reserve.
The vendor's capability footprint is narrow and specialized. Genomic Testing Cooperative delivers 177-gene hematology panel sequencing on bone marrow samples to detect somatic mutations associated with blood disorders, hematologic malignancies, and bone marrow failure syndromes. The work supports NHLBI's Young Lab biomedical research and diagnostic initiatives, with turnaround time of ten calendar days from specimen receipt through final analysis and reporting. The contractor maintains CLIA certification, performs automated DNA and RNA extraction, and provides secure electronic reporting with authenticated access controls. Representative awards include a $216 thousand ceiling purchase order (June 2026) for ongoing NGS testing of bone marrow samples with a one-year performance window; a $114 thousand order (November 2022) for next-generation sequencing on 177 genes; and a $90 thousand order (December 2023) for detection of somatic gene mutations in patients. The source notes the firm has received contracts totaling over $650 thousand since 2021 and describes capabilities in tumor profiling and cancer biomarker analysis including DNA and RNA testing.
Customer concentration is absolute and singular. All twenty-six awards and 100% of combined potential value ($1.3 million) fund NHLBI programs. The vendor has no identified subcontractor relationships and operates entirely as a prime. Activity has grown modestly — three awards in 2022, one in 2023, four in 2024, six in 2025, and three in 2026 year-to-date — with six awards (combined potential value $336 thousand) reaching ultimate completion inside the next twenty-four months. Award velocity remains low relative to baseline potential value, suggesting either limited utilization against established capacity or a narrow scope of work within NHLBI's larger testing portfolio.
Quick answers
Is Genomic Testing Cooperative, LCA registered in SAM.gov?
Yes. Genomic Testing Cooperative, LCA's SAM.gov registration is active through December 16, 2026.
What is Genomic Testing Cooperative, LCA's CAGE code?
Genomic Testing Cooperative, LCA's CAGE code is 87PF1, and its Unique Entity ID (UEI) is NMAYSL9NW6M9.
How much has Genomic Testing Cooperative, LCA received in federal contracts?
Federal contracts obligated $205,500 to Genomic Testing Cooperative, LCA in fiscal year 2025 and $775,500 in fiscal years 2023 through 2027.
How does Genomic Testing Cooperative, LCA rank among federal contractors?
Genomic Testing Cooperative, LCA ranked #50 in NAICS 621991 in FY2025.
What is Genomic Testing Cooperative, LCA's most recent federal award?
Genomic Testing Cooperative, LCA's most recent federal contract award is Nhlbi: service: next generation sequencing: severable (75N98026P00650), from Office of Logisitics and Acquisition Operations (NIH), on June 5, 2026.
On GovTribe
See Genomic Testing Cooperative, LCA's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors